National Academies Press: OpenBook

Venture Funding and the NIH SBIR Program (2009)

Chapter: Appendix C: NIH List of Firms Excluded on the Grounds of Venture Capital Ownership

« Previous: Appendix B: NRC Non-participant Survey
Suggested Citation:"Appendix C: NIH List of Firms Excluded on the Grounds of Venture Capital Ownership." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

Appendix C
NIH List of Firms Excluded on the Grounds of Venture Capital Ownership*

FIRM NAME

Altus Biologics, Inc.

Applied Genetic Technologies Corp.

Arginox Pharmaceuticals

Argolyn Bioscience, Inc.

Arizeke Pharmaceuticals

Ascenta Therapeutics, Inc.

Aspect Medical Systems, Inc.

Biospect Inc./Predicant Biosciences

BrainCells, Inc.

Calypso Medical Technologies, Inc.

Cell Biosciences

Cengent Therapeutics, Inc.

CEPTYR, Inc.

Cerus Corporation

Chlorogen

CUMBRE, Inc.

Diversa Corp.

Encysive Pharmaceuticals

FivePrime Therapeutics

GlycoFi, Inc.

Gryphon Therapeutics, Inc.

*

These firms were submitted by NIH as an illustrative list of firms they believe were excluded.

Suggested Citation:"Appendix C: NIH List of Firms Excluded on the Grounds of Venture Capital Ownership." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×

Handylab Inc.

IDM Pharma, Inc.

Infigen, Inc.

Inotek Pharmaceuticals

Lincoln Technologies

Macrogenics, Inc.

MEMX

Metabolon, Inc.

MicroOptical Corporation

MicroOptical Engineering Corporation

Myomatrix Therapeutics

NanoMix, Inc.

NanoString Technologies, Inc.

Natus Medical (BioLogics)

Nephros Therapeutics, Inc.

Neurogenetics, Inc.

Norak Biosciences, Inc.

Northwest Medical Physics Equipment

Paratek Pharmaceuticals

Peptx, Inc.

Phenomix Corp.

PTC Therapeutics, Inc.

Saegis Pharmaceuticals Inc.

Sentrx Surgical/Carbylan Biosurgery

Sirtris Pharmaceuticals

Threshold Pharmaceuticals, Inc.

Transave, Inc.

Traxtal, Inc.

Trellis Bioscience

Tularik, Inc.

Vion Pharmaceuticals, Inc.

Virxsys Corp.

VisEn Medical, Inc.

Yasoo Health, Inc.

Suggested Citation:"Appendix C: NIH List of Firms Excluded on the Grounds of Venture Capital Ownership." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page 80
Suggested Citation:"Appendix C: NIH List of Firms Excluded on the Grounds of Venture Capital Ownership." National Research Council. 2009. Venture Funding and the NIH SBIR Program. Washington, DC: The National Academies Press. doi: 10.17226/12543.
×
Page 81
Next: Appendix D: Venture-funded Firms: Data from Hoover's Small Business Database and VentureSource »
Venture Funding and the NIH SBIR Program Get This Book
×
Buy Paperback | $34.50 Buy Ebook | $27.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The Small Business Administration issued a policy directive in 2002, the effect of which has been to exclude innovative small firms in which venture capital firms have a controlling interest from the SBIR program. This book seeks to illuminate the consequences of the SBA ruling excluding majority-owned venture capital firms from participation in SBIR projects.

This book is part of the National Research Council's study to evaluate the SBIR program's quality of research and value to the missions of five government agencies. The other books in the series include:

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!